Table 2. General characteristics of the studied population.
| Groups | Tested for Chikungunya | Tested for Dengue | Total Patients* | ||||
|---|---|---|---|---|---|---|---|
| n (%) | 7,349 (99.72%) | 1,700 (23.07%) | 7,370 (100%) | ||||
| Number of samples positive for arboviral disease (%) | 5,244 (71.35%) | 228 (13.41%) | 5,472 (74.25%) | ||||
| Age (years) Average ± SD | 45.7 ± 17.25 | 41.3 ± 18.99 | 45.8 ± 17.26 | ||||
| Gender distribution n (%) | Female | Male | Female | Male | Female | Male | |
| 4,967 (67.6%) | 2,382 (32.4%) | 1,089 (67.5%) | 600 (35.9%) | 4,977 (67.5%) | 2,393 (32.5%) | ||
| Age/group (years) Average ± SD | 46.2 ± 16.5 | 44.8 ± 18.7 | 57.6 ± 16.7 | 48.4 ± 19.0 | 46.2 ± 16.5 | 44.8 ± 18.7 | |
| Serology Results | Reactive Samples n (%) | 3,625 (72.34%) | 1,619 (67.66%) | 139 (12.76%) | 89 (14.57%) | 3,626* (72.8%) | 1,622* (67.78%) |
| Non-reactive Samples n (%) | 1,282 (25.76%) | 731 (30.55%) | 873 (80.17%) | 479 (78.4%) | 1,290* (25.9%) | 739* (30.88%) | |
| Inconclusive Samples n (%) | 60 (1.21%) | 32 (1.5%) | 77 (7.07%) | 43 (7.04%) | 61* (1.23%) | 32* (1.34%) | |
*—Serology results for the Total Patients’ group included samples from patients with clinical symptoms compatible with Chikungunya and/or Dengue.